Eli Lilly and Company has acquired two investigational positron emission tomography (PET) tracers from Siemens Medical Solutions USA. PET tracers are aimed to image tau (or neurofibrillary) tangles in the brain, one of two known hallmarks ...
Tags: Eli Lilly, Alzheimer's Research
Boehringer Ingelheim and Eli Lilly and Company have announced the submission of new drug application (NDA) to FDA for an investigational type 2 diabetes mellitus (T2D) treatment, empagliflozin. Empagliflozin belongs to sodium glucose ...
Tags: diabetes therapy, drug application, drug
MeadWestvaco Corp., a global provider of packaging and packaging solutions, today announced that its Avive multiple-medication patient adherence solution received the Compliance Package of the Year award from the Healthcare Compliance ...
Denmark-based cancer diagnostics solutions manufacturer Dako announced that it has entered into collaboration agreement with Pfizer in the field of companion diagnostics. The agreement includes a legal framework for various collaboration ...
Tags: cancer diagnostics solutions, Dako, Pfizer
Rigid plastic packaging and devices manufacturer Rexam Healthcare has announced the expansion of its La Verpillière site near Lyon in France to create a building including about 2400m² of clean room. The company will produce ...
Eli Lilly and Company has reported a net income of $827.2m, or $0.74 per diluted share, for the fourth quarter ended 31 December 2012 compared to $858.2m, or $0.77 per diluted share, for the fourth quarter ended 31 December 2011. Total ...
Tags: Eli Lilly, net income, share
Eli Lilly and Company and Avid Radiopharmaceuticals have announced the approval of Amyvid (Florbetapir (18F)) solution for injection in European Union to detect the beta-amyloid neuritic plaque density in patients with cognitive impairment ...
Tags: diagnostic radiopharmaceutical, Eli Lilly Amyvid, disease
Eli Lilly and Company has reassumed the worldwide development and commercialization rights for novel basal insulin analog giving a scope to diabetes alliance signed with Boehringer concerning LY2605541. Lilly also considers initiating ...
Tags: Eli Lilly, commercialization rights, Boehringer, company news
Cardinal Health has entered into an agreement to manufacture and distribute Eli Lilly and Company's new diagnostic imaging agent, Amyvid, at seven sites throughout the US. Amyvid, a radioactive diagnostic agent, tagged with a ...
The US Court of Appeals for the Federal Circuit has confirmed a prior ruling by the US District Court for the District of Delaware that the Eli Lilly and Company's compound patent for Alimta (pemetrexed) is valid. The compound patent ...
Bristol-Myers Squibb will acquire Amylin for $31.00 per share in cash, pursuant to a cash tender offer and second step merger, or a total buying price nearing $5.3bn. The acquisition value includes Amylin's debt proceeds and a contractual ...
Mylan Pharmaceuticals has won final FDA approval for its abbreviated new drug application for Olanzapine tablets USP, 2.5mg, 5mg, 7.5mg, 10mg, 15mg, and 20mg. The company begins the shipment of the product, which is the generic equivalent ...
Tags: Generic Zyprexa Tablets, Mylan Pharmaceuticals, new drug
Eli Lilly and Company and Avid Radiopharmaceuticals have gained positive CHMP opinion for Amyvid (Florbetapir F 18 injection) for the use as a diagnostic tool for positron emission tomography (PET) imaging of beta-amyloid plaque density in ...
Tags: Amyvid, Positive CHMP Opinion, Cognitive Impairment Diagnosis
Eli Lilly and Company Alimta(pemetrexed for injection)has received FDA approval for new use in the continuation maintenance setting for advanced or metastatic nonsquamous non-small cell lung cancer(NS NSCLC). The approval was based on ...
Boehringer Ingelheim India and Eli Lilly India is set to launch Linagliptin (brand name trajenta) 5mg film-coated tablets, for Type 2 diabetes in adults, in India. Linagliptin, which is approved in the US, the European Union, Japan and ...
Tags: Diabetes Drug, product of Boehringer, diabetes epidemic